Skip to main content
. 2021 Sep 30;10(19):4547. doi: 10.3390/jcm10194547

Table 5.

Clinical, hemodynamic data and therapeutic management of patients with CTEPH according to their operability. Categorical variables are presented as frequency and percentage, n (%).

n = 74 Operable n = 34 Non-Operable n = 40 p-Value *
Subjects 34 (45.9) 40 (54.1)
Female 16 (21.6) 27 (36.5) 0.099
Age, years 53 ± 13 63 ± 15 <0.0001
BMI, (kg/m2) 27.0 (8.2) 27.1 (5.7) 0.542
WHO FC
I 5 (14.7) 1 (2.5) 0.037
II 18 (52.9) 16 (40)
III 10 (29.4) 23 (57.5)
IV 1 (2.9) 0
6-MWD, m 420 (202) 347 (206) 0.278
NT-proBNP, pg/mL 570 (1706) 814.0 (1949) 1.0
Right heart catheterization
mRAP, mmHg 8.0 (6.8) 8.5 (8.0) 0.557
mPAP, mmHg 47.5 (20.5) 44 (22) 0.792
PAWP, mmHg 10.0 (4.8) 12 (3.0) 0.758
CO, L/min 4.2 ± 0.8 4.8 ± 1.7 0.385
CI, L/min/m2 2.3 ± 0.4 2.6 ± 0.9 0.357
PVR, WU 9.1 (5.7) 6.8 (6.7) 0.536
HR, bpm 74 ± 8 78 ± 10 0.091
SVO2, % 64.9 ± 8.9 63.6 ± 10 0.375
V/Q scintigraphy (abnormal) 14 (18.9) 13 (17.6) 0.511
Chest CTPA 19 (55.9) 13 (32.5) 0.062
Central thrombi 13 (38.2) 2 (5) 0.008
Peripheral thrombi 10 (29.4) 10 (25) 0.686
Pulmonary Angiography 19 (55.9) 21 (52.5) 0.818
Supportive Therapy
Oxygen therapy 10 (29.4) 15 (37.5) 0.622
Diuretics 14 (18.9) 21 (52.5) 0.359
OAC 27 (79.4) 23 (57.5) 0.051

Continuous variables are presented as mean value ± standard deviation (SD) or median value with interquartile range (IQR). * Statistical significance between operable and inoperable patients with CTEPH: p < 0.05. CTEPH: Chronic Thromboembolic Pulmonary Hypertension; BMI: Body Mass Index; WHO: World Health Organization; FC: Functional Class; 6-MWD: Six-minute Walk Distance; NT-proBNP: N-terminal pro-brain natriuretic peptide; mRAP: mean Right Atrial Pressure; mPAP: mean Pulmonary Artery Pressure; PAWP: Pulmonary Artery Wedge Pressure; CO: Cardiac Output; CI: Cardiac Index; PVR: Pulmonary Vascular Resistance; WU: Wood Units; HR: Heart Rate; bpm: beats per minute; SvO2: oxygen saturation in pulmonary artery; CTPA: Combuted Tomography Pulmonary Angiography, OAC: Oral Anticoagulant.